drugset / Trial / NCT06338163

Polihexanide SSIs Measures Bundle (PSMB) During Enhanced Recovery After Major Digestive Surgery

NCT06338163

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized controlled, prospective, multicenter superiority trial with two parallel treatment groups and single blinding (local investigators performing postoperative follow up will be blinded for group allocation), with prospective enrollment planned from July 2024 to June 2025 in 20 Italian surgical centers. All patients undergoing elective major gastro-intestinal (GI) tract surgery (upper GI, HPB, \& lower GI) will be included in a prospective database after written informed consent. A total of 2,000 patients is expected based on a mean of 100 cases per center.

Timeline

Start
2024-07-01
Primary completion
2025-06-30
Completion
2025-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Polihexanide Other / unclassified 0.04 % Topical
Subject Polihexanide Other / unclassified 0.1 % Topical
Subject Polihexanide Other / unclassified 10 ml Topical
Subject Polihexanide Other / unclassified 50 ml Topical
Subject Polihexanide Other / unclassified 250 ml Topical

Indications

No indication recorded.